Annual Retained Earnings
-$458.58 M
-$188.92 M-70.06%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual retained earnings is -$458.58 million, with the most recent change of -$188.92 million (-70.06%) on December 31, 2023.
- During the last 3 years, DAWN annual retained earnings has fallen by -$401.74 million (-706.77%).
- DAWN annual retained earnings is now -3487.18% below its all-time high of -$12.78 million, reached on December 31, 2019.
Performance
DAWN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$488.37 M
+$37.04 M+7.05%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly retained earnings is -$488.37 million, with the most recent change of +$37.04 million (+7.05%) on September 30, 2024.
- Over the past year, DAWN quarterly retained earnings has dropped by -$29.78 million (-6.49%).
- DAWN quarterly retained earnings is now -759.17% below its all-time high of -$56.84 million, reached on December 31, 2020.
Performance
DAWN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DAWN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.1% | -6.5% |
| 3 y3 years | -706.8% | -112.7% |
| 5 y5 years | -3487.2% | -112.7% |
DAWN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -259.7% | at low | -283.1% | +7.0% |
| 5 y | 5-year | -3487.2% | at low | -759.2% | +7.0% |
| alltime | all time | -3487.2% | at low | -759.2% | +7.0% |
Day One Biopharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$488.37 M(-7.0%) |
| Jun 2024 | - | -$525.40 M(+0.8%) |
| Mar 2024 | - | -$521.00 M(+13.6%) |
| Dec 2023 | -$458.58 M(+70.1%) | -$458.58 M(+13.5%) |
| Sep 2023 | - | -$404.07 M(+12.9%) |
| Jun 2023 | - | -$357.92 M(+14.7%) |
| Mar 2023 | - | -$312.06 M(+15.7%) |
| Dec 2022 | -$269.67 M | -$269.67 M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$229.56 M(+19.7%) |
| Jun 2022 | - | -$191.76 M(+23.5%) |
| Mar 2022 | - | -$155.23 M(+21.8%) |
| Dec 2021 | -$127.49 M(+124.3%) | -$127.49 M(+20.8%) |
| Sep 2021 | - | -$105.55 M(+22.3%) |
| Jun 2021 | - | -$86.31 M(+19.8%) |
| Mar 2021 | - | -$72.02 M(+26.7%) |
| Dec 2020 | -$56.84 M(+344.6%) | -$56.84 M |
| Dec 2019 | -$12.78 M | - |
FAQ
- What is Day One Biopharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual retained earnings year-on-year change?
- What is Day One Biopharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly retained earnings year-on-year change?
What is Day One Biopharmaceuticals annual retained earnings?
The current annual retained earnings of DAWN is -$458.58 M
What is the all time high annual retained earnings for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual retained earnings is -$12.78 M
What is Day One Biopharmaceuticals annual retained earnings year-on-year change?
Over the past year, DAWN annual retained earnings has changed by -$188.92 M (-70.06%)
What is Day One Biopharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of DAWN is -$488.37 M
What is the all time high quarterly retained earnings for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly retained earnings is -$56.84 M
What is Day One Biopharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, DAWN quarterly retained earnings has changed by -$29.78 M (-6.49%)